[Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
Gan To Kagaku Ryoho
; 48(5): 735-737, 2021 May.
Article
en Ja
| MEDLINE
| ID: mdl-34006726
ABSTRACT
Chemotherapy for patients with poor performance status(PS)is not recommended because it increases the risk of death and shortens their survival. We report on 3 cases in which palliative care improved PS and enabled chemotherapy, resulting in a prolonged prognosis. Case 1 involves a 57âyearâold woman with multiple lung, liver, and bone metastases from breast cancer who was administered celecoxib and oxycodone. She received Mohs paste therapy. Her PS improved from 3 to 2, and paclitaxel and trastuzumab were started; however, the patient died on day 861. Case 2 involves a 53âyearâold woman with multiple lymph node metastases from carcinoma of an unknown primary cause. She was administered oxycodone, loxoprofen, and dexamethasone. Her PS improved from 4 to 3. The biopsy of her bone marrow showed diffuse large Bâcell lymphoma. The patient is still alive, 6 years and 10 months after the introduction of RâCHOP. In case 3, a 57âyearâold man with multiple bone metastases from small cell lung cancer was administered loxoprofen and betamethasone. His PS improved from 4 to 3. Etoposide and carboplatin were administered to him, but the patient died on day 692. Palliative care may enable the introduction of chemotherapy and consequently improve prognosis.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Cuidados Paliativos
/
Neoplasias de la Mama
Tipo de estudio:
Prognostic_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ja
Año:
2021
Tipo del documento:
Article